dizziness and semaglutide why does cause #Ozempic, #Wegovy, #GLP1, #Semaglutide, #DrugSafety GLP-1 and Low Blood Pressure:
Description
Semaglutide is a class of medication called glucagon-like peptide 1 (GLP-1) approved for the treatment of obesity or overweight adults with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

A person with normal overall body weight but elevated visceral fat (sometimes called TOFI: Thin Outside, Fat Inside) may have worse metabolic health markers than someone who is visibly overweight but carries their fat subcutaneously

Quick Answer: Compounded semaglutide often has a Beyond-Use Date (BUD) of 28 to 90 days depending on the pharmacys specific formulation and testing

Cardiovascular exercise supports overall health and can increase the caloric deficit, but it should not come at the expense of resistance training
